• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and Medicaid Programs.通过法律手段确保在惩教机构和医疗补助计划中使用直接作用抗病毒疗法治疗丙型肝炎病毒
Public Health Rep. 2020 Jul/Aug;135(1_suppl):44S-49S. doi: 10.1177/0033354920904608.
2
Funding Hepatitis C Treatment in Correctional Facilities by Using a Nominal Pricing Mechanism.通过使用名义定价机制为惩教机构中的丙型肝炎治疗提供资金。
J Correct Health Care. 2019 Jan;25(1):15-24. doi: 10.1177/1078345818805770. Epub 2018 Oct 15.
3
Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs.州医疗补助计划下新型丙型肝炎病毒治疗的获取受限。
Ann Intern Med. 2015 Aug 4;163(3):226-8. doi: 10.7326/M15-0320.
4
Adopting more systematic approaches to hepatitis C treatment in correctional facilities.
Ann Intern Med. 2003 Feb 4;138(3):235-6. doi: 10.7326/0003-4819-138-3-200302040-00021.
5
State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals.州医疗补助丙型肝炎治疗资格标准和直接作用抗病毒药物的使用。
Clin Infect Dis. 2018 May 2;66(10):1618-1620. doi: 10.1093/cid/cix1062.
6
Early Patterns of Sofosbuvir Utilization by State Medicaid Programs.各州医疗补助计划中索磷布韦的早期使用模式。
N Engl J Med. 2015 Sep 24;373(13):1279-81. doi: 10.1056/NEJMc1506108.
7
Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.医疗补助计划对用于治疗慢性丙型肝炎的口服直接抗病毒药物的报销情况。
Am J Gastroenterol. 2017 Jun;112(6):828-832. doi: 10.1038/ajg.2017.87. Epub 2017 Apr 4.
8
A Novel Strategy for Increasing Access to Treatment for Hepatitis C Virus Infection for Medicaid Beneficiaries.一种增加医疗补助受益人获得丙型肝炎病毒感染治疗机会的新策略。
Ann Intern Med. 2018 Jul 17;169(2):118-119. doi: 10.7326/M18-0186. Epub 2018 May 15.
9
Treatment strategy for hepatitis C: a dilemma for the payers and the providers.丙型肝炎的治疗策略：支付方和医疗服务提供者面临的困境。
Am J Gastroenterol. 2014 Dec;109(12):1953-4. doi: 10.1038/ajg.2014.320.
10
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.美国医疗补助计划对索磷布韦治疗丙型肝炎病毒感染的报销限制。
Ann Intern Med. 2015 Aug 4;163(3):215-23. doi: 10.7326/M15-0406.

引用本文的文献

1
Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics?注射吸毒者中的严重细菌感染与丙型肝炎病毒：一种综合征还是相互交织的流行病？
Trop Med Infect Dis. 2025 Jan 9;10(1):17. doi: 10.3390/tropicalmed10010017.
2
Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States.通过在监禁场所实施默认普遍筛查和治疗来推进丙型肝炎消除工作，美国。
Emerg Infect Dis. 2024 Apr;30(13):S80-S87. doi: 10.3201/eid3013.230859.
3
Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States.提高高价值、高成本药品的可及性：在美国使用订阅模式治疗丙型肝炎的直接作用抗病毒药物。
J Health Polit Policy Law. 2022 Dec 1;47(6):691-708. doi: 10.1215/03616878-10041121.
4
Sustained Virologic Response Rates Before and After Removal of Sobriety Restriction for Hepatitis C Virus Treatment Access.在放宽对丙型肝炎病毒治疗准入的清醒限制前后的持续病毒学应答率。
Public Health Rep. 2023 May-Jun;138(3):467-474. doi: 10.1177/00333549221099323. Epub 2022 Jun 8.
5
Uptake of hepatitis C virus treatment in a multi-state Medicaid population, 2013-2017.2013-2017 年，多州医疗补助计划人群中丙型肝炎病毒治疗的吸收率。
Health Serv Res. 2022 Dec;57(6):1312-1320. doi: 10.1111/1475-6773.13994. Epub 2022 May 4.
6
Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness.在针对无家可归者的基于现场庇护所的丙型肝炎护理模式中，正规的丙型肝炎教育可提高接受治疗的意愿。
Open Forum Infect Dis. 2022 Mar 1;9(4):ofac103. doi: 10.1093/ofid/ofac103. eCollection 2022 Apr.
7
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019.2017-2019 年美国丙型肝炎病毒感染者的流行病学和临床特征。
Adv Ther. 2021 Dec;38(12):5777-5790. doi: 10.1007/s12325-021-01928-y. Epub 2021 Oct 27.
8
Policy and Public Health : Reducing the Burden of Infectious Diseases.政策与公共卫生：减轻传染病负担
Public Health Rep. 2020 Jul/Aug;135(1_suppl):5S-9S. doi: 10.1177/0033354920932641.

本文引用的文献

1
Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity.美国改善丙型肝炎治疗可及性的策略：州官员应对高药价、耻辱感及提升治疗能力问题
J Public Health Manag Pract. 2019 May/Jun;25(3):245-252. doi: 10.1097/PHH.0000000000000829.
2
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.索磷布韦和维帕他韦治疗近期有注射吸毒史的丙型肝炎病毒感染（SIMPLIFY）：一项开放标签、单臂、4 期、多中心试验。
Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6.
3
Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents.接受直接抗病毒药物治疗的患者中酒精使用与丙型肝炎病毒治疗结果
Drug Alcohol Depend. 2016 Dec 1;169:101-109. doi: 10.1016/j.drugalcdep.2016.10.021. Epub 2016 Oct 22.

Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and Medicaid Programs.

作者信息

Greenwald Robert, Waters Phillip, Cayer Sarah

机构信息

Center for Health Law and Policy Innovation, Harvard Law School, Cambridge, MA, USA.

出版信息

Public Health Rep. 2020 Jul/Aug;135(1_suppl):44S-49S. doi: 10.1177/0033354920904608.

DOI:10.1177/0033354920904608
PMID:32735189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7407058/
Abstract
摘要